Renoprotective effect of combining angiotensin II receptor blockers and statins in diabetic rats

Chinese Medical Journal

Volumn 118, Issue 7, 2005, Pages 598-602

  Gao, Ping ^a   Jia, Ru Han ^a   Yang, Ding Ping ^a   Liu, Hong Yan ^a   Song, En Feng ^a   Chu, Gui Li ^a   Ding, Guo Hua ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Angiotensin II type 1 receptor blockers; Diabetes mellitus; Monocyte chemoattractant protein 1; NF kappa B; Statins

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; EXPERIMENTAL DIABETES MELLITUS; GEL MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; MALE; NEPHRECTOMY; NONHUMAN; RAT; RAT STRAIN; RENAL PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STREPTOZOCIN DIABETES;

ANIMALS; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; INDOLES; KIDNEY; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TETRAZOLES; TRANSCRIPTION FACTOR RELA; VALINE;

EID: 17144401494     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Liu BC, Sun J, Chen Q, et al. Effect of irbesartan on angiotensin II-induced hypertrophy of human proximal tubular cells. Chin Med J 2004;117:547-551.
2. Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 2003;18:265-272.
3. Aoyama I, Shimokata K, Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 2002;92-635-651.
4. Chen X, Liu W, Wang J, et al. STAT1 and STAT3 mediate thrombin-induced expression of tissue inhibitor of metalloproteinase-1 in human glomerular mesangial cells. Kidney Int 2002;13:1377-1382.
5. Wolf G. Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 2000;77:s59-s66.
6. Michael M, Ahmed ARS, Angelika B, et al. Activation of tubular epitheliall cells in diabetic nephropathy. Diabetes 2002;51:3532-3544.
7. Elisaf M, Mikhailidis DP. Statins and renal function. Angiology 2002;53:493-502.
8. Wolf G, Wenzel U, Burns KD, et al. Angiotensin II activates nuclear transcription factor-B through AT1 and AT2 receptors. Kidney Int 2002;61:1986-1995.
9. Park JK, Muller DN, Mervaala EM, et al. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int 2000;58:1420-1430.
10. Massy ZA, Guijarro C. Statins: effects beyond cholesterol lowering. Nephrol Dial Transplant 2001;16: 1738-1741.
11. Zoja C, Corna D, Rottoli D, et al. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int 2002;61:1635-1645.
12. Jie Q, Zhili Z, Jie L, et al. Effects of the combination of an angiotensin II blockers with an HMG-COA reductase inhibitor in experimental diabetes. Kidney Int 2003;64:565-571.
13. Borghi C, Veronesi M, Prandin MG, et al. Statins and blood pressure regulation. Curr Hypertens Rep 2001; 3:281-288.